We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

585 hedge funds and large institutions have $2.19B invested in iShares US Medical Devices ETF in 2023 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 168 increasing their positions, 233 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 38

5% more funds holding

Funds holding: 557585 (+28)

0% more funds holding in top 10

Funds holding in top 10: 1515 (0)

4% less capital invested

Capital invested by funds: $2.28B → $2.19B (-$81.5M)

2.34% less ownership

Funds ownership: 38.08%35.74% (-2.3%)

28% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 233

32% less call options, than puts

Call options by funds: $12.4M | Put options by funds: $18.1M

Holders
585
Holders Change
+28
Holders Change %
+5.03%
% of All Funds
9.19%
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.24%
New
68
Increased
168
Reduced
233
Closed
38
Calls
$12.4M
Puts
$18.1M
Net Calls
-$5.71M
Net Calls Change
-$14M
Name Holding Trade Value Shares
Change
Change in
Stake
AWA
376
Arkadios Wealth Advisors
Georgia
$311K +$19.7K +358 +7%
NFSG
377
Newbridge Financial Services Group
Florida
$310K -$8.32K -151 -3%
PCM
378
Pennsylvania Capital Management
Pennsylvania
$309K -$47.5K -863 -14%
SFM
379
Signet Financial Management
New Jersey
$305K +$6.61K +120 +2%
MSCM
380
McElhenny Sheffield Capital Management
Texas
$302K
IAG
381
Investmark Advisory Group
Connecticut
$299K +$291K +5,288 New
AWA
382
Acorn Wealth Advisors
Michigan
$298K -$31.6K -574 -10%
RIA
383
Realta Investment Advisors
Delaware
$293K +$33.1K +601 +13%
CAM
384
Cresset Asset Management
Illinois
$291K +$284K +5,159 New
Bank of New York Mellon
385
Bank of New York Mellon
New York
$289K +$282K +5,117 New
FIA
386
Foundations Investment Advisors
Arizona
$288K +$50.2K +912 +22%
GCP
387
GSA Capital Partners
United Kingdom
$284K +$277K +5,022 New
SWM
388
SeaCrest Wealth Management
New York
$282K +$7.43K +135 +3%
MIA
389
MMBG Investment Advisors
Florida
$282K
SIS
390
Strategic Investment Solutions
Illinois
$278K -$148K -2,682 -34%
PFG
391
Prosperity Financial Group
California
$277K -$33K -600 -11%
YIH
392
Y-Intercept (HK)
Hong Kong
$274K -$3.08K -56 -1%
CCA
393
Column Capital Advisors
Indiana
$274K
SRSA
394
S.R. Schill & Associates
Washington
$271K +$14.5K +263 +6%
SFP
395
Sterling Financial Planning
New Jersey
$271K +$110 +2 +0%
AIM
396
Acropolis Investment Management
Missouri
$271K
SFI
397
SPC Financial Inc
Maryland
$268K
BIA
398
Biondo Investment Advisors
Pennsylvania
$267K +$34.1K +620 +15%
FAM
399
Forte Asset Management
New York
$265K -$27.2K -494 -10%
TCWM
400
Total Clarity Wealth Management
Illinois
$261K +$20.8K +378 +9%

IHI Hedge Fund Activity: Q2 2023 in Review

585 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2023, worth a combined $2.19B — down 3.6% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new IHI positions and 38 closed out — a net gain of 30 holders — while 168 added to existing stakes and 233 trimmed.

The largest buyer was LPL Financial, adding an estimated $13.5M. The largest seller was Menora Mivtachim Holdings, exiting entirely with an estimated $107M sold.

  • 585 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2023, up from 557 in Q1 2023.
  • Funds reported $2.19B of iShares US Medical Devices ETF stock for Q2 2023, down 3.6% quarter-over-quarter.
  • 68 funds opened new iShares US Medical Devices ETF positions in Q2 2023 and 38 closed out, a net change of +30 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2023 was LPL Financial, an estimated $13.5M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2023 was Menora Mivtachim Holdings, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.